“Dexmedetomidine alleviates hippocampal neuronal damage in epilepsy through BDNF/TrkB pathway by inhibiting MeCP2” (2024) Indian Journal of Biochemistry and Biophysics (IJBB), 61(4), pp. 241–251. doi:10.56042/ijbb.v61i4.8422.